Drawing for IGNITE BIOSCIENCES

USPTO serial 87269612

IGNITE BIOSCIENCES

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
LEIPZIG, MARC J
Law office
TMO LAW OFFICE 115 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with IGNITE BIOSCIENCES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Elizabeth Oliner

ELIZABETH OLINER OLINER LAW345 GROVE STREET2ND FLOORSAN FRANCISCO, CA 94102

Goods and services

ClassDescriptionStatusFirst use
001Reagents for research purposes; Reagents for scientific and research use; Reagents for scientific or medical research use; Reagents for use in scientific apparatus for chemical or biological analysis; Diagnostic reagents for scientific or research use; Diagnostic reagents for scientific use; Assays and reagents for use in biologic and medical research; diagnostic reagents for scientific or research use; diagnostic reagents for clinical or medical laboratory use; reagents and reagent kits comprised primarily of amino acids, naturally occurring or modified proteins, affinity reagents, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, quantifying and analyzing proteins and other biological molecules, samples of biological molecules, proteins, proteomes, protein sequence variants and modifications, regulation, translation, and expression in the fields of scientific, diagnostic and clinical researchACTIVE—
009Medical laboratory research instruments for proteome measurements; Medical laboratory research instruments for use in large cohort biomarker studies; Medical laboratory research instruments for identifying biochemical mechanisms underlying disease processes; Medical laboratory research instruments for discovery of potential drug targets; ; Automated laboratory apparatus and computer systems for use in analysis of biomolecules; proteome quantifiers, imaging devices, namely, electronic imaging apparatus for detecting images and optical signals, and for processing images and optical signals into data, for use in the analysis of biomolecules, and analyzers for use in scientific research; ; laboratory equipment, namely, fluid containers, fluid mixers, fluid control valves and temperature-controlled incubators for sample preparation, amplification, mixing, hybridization, incubation, and washing; automated laboratory apparatus and systems, namely, sample loaders and bar code readers; computer systems, namely, computer hardware, computer software, and data files for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects,; ; laboratory workflow and data, all the foregoing for use in the fields of scientific research; computer software for data collection, management, and analysis of genetic information for use in the field of scientific researchACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Oct 18, 2017MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 18, 2017ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 22, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 22, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 22, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 17, 2017DOCKASSIGNED TO EXAMINER—
Dec 21, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 19, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance